Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

AstraZeneca follows GSK with $1.5B annual savings push

Battered by late-stage trial failures and determined to meet its ambitious $80 billion-by-2030 revenue goal, AstraZeneca is cutting costs. The company said Friday that it was shifting resources with ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

Liberia: NPHIL Says No Ebola in Liberia

[Liberian Observer] The National Public Health Institute of Liberia (NPHIL) has assured lawmakers that no Ebola outbreak has been reported in Liberia, urging public institutions to install handwashing…

More from Friday 30 October →